Physician profile
John E Samani
NPI 1679678759
$7,898.80
in general payments reported to CMS, 2019-2025
21 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,416 · 2020: $2,087 · 2021: $221 · 2022: $519 · 2023: $295 · 2024: $188 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $5,800.33 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $844.78 | 2019-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $361.47 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $151.84 | 2022-2023 | |
| Smith+Nephew, INC. | $143.50 | 2022-2023 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Biceptor |
| Sanofi-Aventis U.S. LLC | $111.67 | 2019-2023 | |
| Depuy Synthes Sales INC. | $100.79 | 2020-2023 | Monovisc, Orthovisc, Peak |
| Bioventus LLC | $48.43 | 2021-2024 | Gelsyn-3 |
| Stryker Corporation | $39.64 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $38.15 | 2024-2025 | |
| Baxter Healthcare | $34.58 | 2022 | |
| Nevro Corp. | $30.38 | 2024 | Senza |
| Conformis, INC. | $29.15 | 2019-2022 | |
| Linvatec Corporation | $27.89 | 2021 | |
| Embody, INC. | $27.10 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $25.43 | 2020-2022 | |
| Abbott Laboratories | $23.80 | 2022 | |
| Heron Therapeutics, INC. | $17.31 | 2022 | |
| Pfizer INC. | $14.48 | 2019 | |
| Avanos Medical | $14.13 | 2019 | |
| Ermi LLC | $13.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Samani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.